Barow, Ewgenia http://orcid.org/0000-0003-2318-0959
,
Boutitie, Florent
Cheng, Bastian
Cho, Tae-Hee
Ebinger, Martin
Endres, Matthias
Fiebach, Jochen B.
Fiehler, Jens
Ford, Ian
Galinovic, Ivana
Nickel, Alina
Puig, Josep
Roy, Pascal
Wouters, Anke
Thijs, Vincent
Lemmens, Robin
Muir, Keith W.
Nighoghossian, Norbert
Pedraza, Salvador
Simonsen, Claus Z.
Gerloff, Christian
Thomalla, Götz
Article History
Received: 11 February 2019
Accepted: 13 May 2019
First Online: 3 June 2019
Conflict of interest
: E. Barow received grants from the European Union 7th Framework Program during the conduct of the study and grants from the German Parkinson Society and ACTELION Pharmaceuticals Deutschland GmbH, outside the submitted work. F. Boutitie received grants from the University Medical Center Hamburg-Eppendorf during the conduct of the study. M. Ebinger received grants from the European Union 7th Framework Program during the conduct of the study. M. Endres received grants from European Union 7th Framework Program during the conduct of the study, grants from the Bayer and fees paid to the Charité from Bayer, Boehringer Ingelheim, BMS/Pfizer, Daiichi Sankyo, Amgen, GlaxoSmithKlineGSK, Sanofi, Covidien, Ever, Novartis, all outside the submitted work. J.B. Fiebach received grants from the European Union 7th Framework Program during the conduct of the study and personal fees from Bioclinica, Artemida, Cerevast, and Nicolab outside the submitted work. I. Galinovic received grants from the European Union 7th Framework Program during the conduct of the study. A. Nickel received grants from European Union 7th Framework Program during the conduct of the study. P. Roy received grants from the European Union 7th Framework Program during the conduct of the study. V. Thijs received grants from the European Union 7th Framework Program and personal fees and non-financial support from Boehringer Ingelheim, Pfizer/BMS, Bayer, Sygnis, Amgen and Allergan outside the submitted work. K.W. Muir received grants from the European Union 7th Framework Program during the conduct of the study, personal fees and non-financial support from Boehringer Ingelheim outside the submitted work. S. Pedraza received grants from the European Union 7th Framework Program during the conduct of the study. C.Z. Simonsen received grants from Novo Nordisk Foundation and personal fees from Bayer outside the submitted work. C. Gerloff received from the European Union 7th Framework Program during the conduct of the study, personal fees from AMGEN, Bayer Vital, BMS, Boehringer Ingelheim, Sanofi Aventis, Abbott, and Prediction Biosciences outside the submitted work. G. Thomalla received grants from the European Union 7th Framework Program during the conduct of the study, personal fees from Acandis, Boehringer Ingelheim, BMS/Pfizer, Stryker, Daiichi Sankyo, grants and personal fees from Bayer, grants from Corona Foundation, German Innovation Fonds and Else Kroener Fresenius Foundation outside the submitted work. B. Cheng, T.-H. Cho, J. Fiehler, I. Ford, J. Puig, A. Wouters, R. Lemmens and N. Nighoghossian declare that they have no competing interests.